← Eichor
Condition: Distantly Metastatic Malignant Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Distantly Metastatic Malignant Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Identification of Therapeutic Targets in Metastatic Gastric Cancer
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07551440Musculoskeletal Cancers Remote Monitoring and Care
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07129226[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Phase 2 · 1 location(s) · Asan Medical Center · NCT07314073TCF-001 TRACK (Target Rare Cancer Knowledge) Study
NA · 1 location(s) · TargetCancer Foundation · NCT04504604A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locall
Phase 1/Phase 2 · 2 location(s) · Asan Medical Center · NCT06732856SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After
Phase 2 · 2 location(s) · The First Affiliated Hospital of Xiamen University · NCT06676722Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT04544969Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NA · 17 location(s) · Danish Breast Cancer Cooperative Group · NCT03646955High-Risk prostatE Cancer radiatiOn Versus surgERy
Phase N/A · 28 location(s) · Comprehensive Cancer Centre The Netherlands · NCT05931419A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurre
Phase 3 · 22 location(s) · Rakuten Medical, Inc. · NCT06699212Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radi
NA · 1 location(s) · Emory University · NCT06662058PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NP
Phase 3 · 5 location(s) · Sun Yat-sen University · NCT07235319A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Met
Phase 2 · 1 location(s) · Asan Medical Center · NCT05184803Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
NA · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06855654Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
NA · 2 location(s) · The Third People's Hospital of Chengdu · NCT06652750Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access an
Phase 2 · 1 location(s) · Mayo Clinic · NCT06265285Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nas
Phase 3 · 1 location(s) · Ming-Yuan Chen · NCT07188584Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whol
Phase N/A · 2 location(s) · Sun Yat-sen University · NCT06831357Remote Monitoring and Symptom Management Digital Application
NA · 1 location(s) · Patrick C. Johnson, MD · NCT07553572
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.